Jakob Dupont

CIK: 0001553335

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (5.6%)

Position reduction

Option Exercises (M)1 (5.6%)

Derivative conversions

Awards (A)12 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)4 (22.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

PYXS

Pyxis Oncology, Inc.

Director

BOLT

Bolt Biotherapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (18 total)

PYXS
Pyxis Oncology, Inc.
Aug 20, 2026
Award(A)
Stock Option (Right to Buy)
Direct
46K shares-
PYXS
Pyxis Oncology, Inc.
Jun 30, 2026
Sale(S)
Direct
35K shares at avg. $3.06$107K
PYXS
Pyxis Oncology, Inc.
Jun 30, 2026
Exercise(M)
Direct
35K shares at avg. $1.60$56K
BOLT
Bolt Biotherapeutics, Inc.
Jun 10, 2026
Award(A)
Stock Option (Right to Buy)
Direct
5K shares-
PYXS
Pyxis Oncology, Inc.
Mar 24, 2026
Award(A)
Stock Option (Right to Buy)
Direct
45.9K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
1.1K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
849 shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
849 shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
1K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
1K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
1.1K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Award(A)
Director Stock Option (Right to Buy)
Direct
2.5K shares-
BOLT
Bolt Biotherapeutics, Inc.
Dec 12, 2025
Disposition(D)
Director Stock Option (Right to Buy)
Direct
2.5K shares-
BOLT
Bolt Biotherapeutics, Inc.
May 27, 2025
Award(A)
Stock Option (Right to Buy)
Direct
1.1K shares-
BOLT
Bolt Biotherapeutics, Inc.
May 1, 2025
Award(A)
Stock Option (Right to Buy)
Direct
20K shares-
PYXS
Pyxis Oncology, Inc.
Mar 31, 2025
Award(A)
Stock Option (Right to Buy)
Direct
37K shares at avg. $0.98-
BOLT
Bolt Biotherapeutics, Inc.
Sep 3, 2024
Award(A)
Stock Option (Right to Buy)
Direct
50K shares-
BOLT
Bolt Biotherapeutics, Inc.
Sep 3, 2024
Award(A)
Stock Option (Right to Buy)
Direct
17K shares-

		Type	Shares	Price		Ownership
Aug 20, 2026	PYXS Pyxis Oncology, Inc.	Award(A) Stock Option (Right to Buy)	46,000	-	-	Direct
Jun 30, 2026	PYXS Pyxis Oncology, Inc.	Sale(S)	35,000	$3.06	$107,100	Direct
Jun 30, 2026	PYXS Pyxis Oncology, Inc.	Exercise(M)	35,000	$1.60	$56,000	Direct
Jun 10, 2026	BOLT Bolt Biotherapeutics, Inc.	Award(A) Stock Option (Right to Buy)	5,000	-	-	Direct
Mar 24, 2026	PYXS Pyxis Oncology, Inc.	Award(A) Stock Option (Right to Buy)	45,867	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	1,100	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	849	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	849	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	1,000	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	1,000	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	1,100	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Director Stock Option (Right to Buy)	2,500	-	-	Direct
Dec 12, 2025	BOLT Bolt Biotherapeutics, Inc.	Disposition(D) Director Stock Option (Right to Buy)	2,500	-	-	Direct
May 27, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Stock Option (Right to Buy)	1,100	-	-	Direct
May 1, 2025	BOLT Bolt Biotherapeutics, Inc.	Award(A) Stock Option (Right to Buy)	20,000	-	-	Direct
Mar 31, 2025	PYXS Pyxis Oncology, Inc.	Award(A) Stock Option (Right to Buy)	36,979	$0.98	-	Direct
Sep 3, 2024	BOLT Bolt Biotherapeutics, Inc.	Award(A) Stock Option (Right to Buy)	50,000	-	-	Direct
Sep 3, 2024	BOLT Bolt Biotherapeutics, Inc.	Award(A) Stock Option (Right to Buy)	16,984	-	-	Direct

1-18 of 18 transactions

About Dupont Jakob

Dupont Jakob (SEC CIK 0001553335) files insider reports with the SEC as Director of Pyxis Oncology, Inc. (PYXS) and Director of Bolt Biotherapeutics, Inc. (BOLT).

Signal8 holds 10 ownership filings by Dupont Jakob (1 Form 3, 9 Form 4), filed between Sep 6, 2024 and Aug 20, 2026. Those filings report 18 transactions, from Sep 3, 2024 to Aug 20, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Dupont Jakob's filings is in BOSTON, MA.

Recent filings by Dupont Jakob

Aug 20, 2026: Grant or award of PYXS derivative securities (Form 4, code A).
Jun 30, 2026: Open-market sale of PYXS shares (Form 4, code S).
Jun 30, 2026: Option exercise of PYXS shares (Form 4, code M).
Jun 10, 2026: Grant or award of BOLT derivative securities (Form 4, code A).
Mar 24, 2026: Grant or award of PYXS derivative securities (Form 4, code A).

Other insiders filing for Pyxis Oncology, Inc. (PYXS)

GordonMD Global Investments LP, 10% Owner
Civik Thomas, CEO & Chairman of the Board
Wadhane Jitendra, Prin Fin & Acct Officer
FLAVIN JOHN L, Director
Metzger Michael A, Director
Lewis-Hall Freda C, Director

How to read Form 4 transaction codes